Connect with Sona

  •  

Email: info@sonanano.com

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

lateral flow test

Sona Develops Rapid Screening Test for Coronavirus

  HALIFAX, Feb 10, 2020 — Sona Nanotech Inc. (“Sona”) (CSE: SONA) is deploying its proprietary nanotechnology in the development of a rapid screening test for the current Coronavirus, “nCoV19”. Sona is developing a quick-response lateral-flow test to screen patients … Read More

NativeAntigen & Sona Nanotech

Sona announces key partner for Coronavirus Rapid Screening Test

Halifax, Nova Scotia, Feb. 13, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) has secured an agreement with The Native Antigen Company (“Native”) to supply biologics for the recently announced Covid-19 Coronavirus rapid screening test, currently in development by Sona … Read More

Challenging the lateral flow sector at ALFC 2019

Last year Sona Nanotech attended the Advanced Lateral Flow Course as the ‘new kids on the block’, keen to show the lateral flow sector what we could do. Twelve months on and with a series of successful collaborations under our … Read More